Evalution of ultraselective transcatheter tumor feeding arterial embolization with ethanol and lipidol for small hepatocellular carcinoma (SHCC) in 95 cases

LUO Xiao-ping; et al

您当前的位置：

首页 >

文章列表页 >

Evalution of ultraselective transcatheter tumor feeding arterial embolization with ethanol and lipidol for small hepatocellular carcinoma (SHCC) in 95 cases

更新时间：2024-01-17

- Evalution of ultraselective transcatheter tumor feeding arterial embolization with ethanol and lipidol for small hepatocellular carcinoma (SHCC) in 95 cases
- Journal of Chongqing Medical University Vol. 34, Issue 7, Pages: 951-954(2009)
- 作者机构：
  
  重庆医科大学附属第二医院放射介入中心
- 作者简介：
- 基金信息：
- DOI：
  CLC： R735.7
- Published：2009，
扫描看全文
[1]罗小平,谢微波,何明菊.小肝癌肿瘤滋养动脉超选择性无水乙醇栓塞治疗的临床价值(附95例报告)[J].重庆医科大学学报,2009,34(07):951-954.

LUO Xiao-ping, et al. Evalution of ultraselective transcatheter tumor feeding arterial embolization with ethanol and lipidol for small hepatocellular carcinoma (SHCC) in 95 cases. [J]. Journal of Chongqing Medical University 34(7):951-954(2009)
[1]罗小平,谢微波,何明菊.小肝癌肿瘤滋养动脉超选择性无水乙醇栓塞治疗的临床价值(附95例报告)[J].重庆医科大学学报,2009,34(07):951-954. DOI：

LUO Xiao-ping, et al. Evalution of ultraselective transcatheter tumor feeding arterial embolization with ethanol and lipidol for small hepatocellular carcinoma (SHCC) in 95 cases. [J]. Journal of Chongqing Medical University 34(7):951-954(2009) DOI：

摘要

目的:回顾性评价小肝癌滋养动脉超选择性插管无水乙醇栓塞治疗的安全性、技术成功率、疗效

以探索小肝癌治疗的新途径。方法:对CT或MRI等检查发现的小肝癌或临床高度怀疑小肝癌者95例实施选择性肝动脉造影检查

经DSA证实后

以微导管对小肝癌滋养动脉行超选择性亚节段插管

并以无水乙醇+超液态碘油（1∶1）对143个病灶实施完全性充填栓塞。结果:95例共143个小肝癌病灶超选择性插管、栓塞技术成功100%

全部病例术后无严重并发症发生。术前病灶直径0.5

平均直径2.3cm;术后3月复查

肿瘤平均直径1.2cm。术后1、3、5年复发率分别为19%（18/95）、27%（26/95）、37%（35/95）。1、3、5年生存率分别为100%（95/95）、85%（81/95）、67%（64/95）。结论:小肝癌滋养动脉超选择性插管并无水乙醇栓塞治疗疗效显著、并发症发生率极低、术后复发率低于外科切除术

应作为小肝癌治疗首选方法。

Abstract

Objective:To retrospectively evaluate the safety

technical success rate

and effectiveness of ultratranscatheter tumor feeding arterial embolization with ethanol and lipidol for SHCC

and to explore the new therapy for SHCC. Methods:To 95 cases carry out hepatic selective arterial angiography for SHCC by CT or MRI be diagnosed and clinical very doubt be SHCC

after was diagnosed by DSA

to transcatheter ultraselective subsegmental feeding artery with microcatheter for tumor

employ ethanol and lipidol (1/1) to full fill embolized 143 tumors. Results:Technical success rate was 100% for the ultraselective subsegmental feeding artery transcatheter and embolizatoin in SHCC

There were no major complications in all cases.Before embolization

the diameter of tumors were 0.5~3cm

average diameter 2.3 cm. after tumors were embolized

average diameter 1.2 cm. The 1

3and 5 year recurrence rates were 19%(18/95)

27%(26/95)

37%(35/95)

and the survival rates were 100%(95/95)

85%(81/95)

67%(64/95) respectively. Conclusion:Its effectiveness was very notable

there were no major complications and recurrence rates was less than surgical resection in ultraselective transcatheter tumor feeding arterial embolization with ethanol and lipidol for SHCC

It should become the first selective therapy for SHCC.

关键词

小肝癌栓塞超选择性无水乙醇碘油

Keywords

Small hepatocellular carcinoma(SHCC)embolizationUltraselectiveEthanolLipidol

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Appilcation value and clinical curative effectiveness of ethanol in transcatheter arterial embolization for hepatocllular carcinoma(HCC) with portal vein tumor thrombus

Endovascular treatment for multiple intracranial aneurysms

The role of the ligament of Marshall in the development of atrial fibrillation in canines and its electrical isolation method

Clinical application of 320-detector row CT perfusion imaging in evaluating the activity of residual hepatocellular carcinoma after TACE

Causes and prevention of rebleeding after applying super-selective renal arterial embolization for renal danage

Related Author

何明菊

何锦江

et al

LUO Xiao-ping

He Zhaohui

Zhu Ji

Sun Xiaochuan

Zhang Xiaodong

Related Institution

Center of Interventional Treatment,the Second Affiliated Hospital,Chongqing Medical University

Department of Neurosurgery,The First Affiliated Hospital of Chongqing Medical University

Department of ICU,the Second Affiliated Hospital,TsingHua University

首都医科大学附属北京安贞医院心内科

郑州大学第一附属医院心内科

⁰